Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Directorate Change

18 Nov 2014 07:00

RNS Number : 2923X
Quindell PLC
18 November 2014
 



Quindell Plc

 

("Quindell" or the "Company" or the "Group")

 

Directorate Change

 

Quindell Plc (AIM: QPP.L), a market leading global provider of professional services and digital solutions, announces that Robert Terry, the Company's Chairman, has resigned from the Board of Directors with immediate effect.

 

The Directors believe that, in order to ensure an orderly transition, it is desirable to retain Mr Terry on a consultancy basis with particular focus on the Group's key relationships and he will be available to assist the Board, where appropriate, in executing its strategy.

 

David Currie will become non-Executive Interim Chairman of the Company with immediate effect and a process has begun to find a new Chairman.

 

Laurence Moorse, Group Finance Director, has agreed with the Company that, following the 2015 Annual General Meeting of the Company, he will step down from the Board. Mr Moorse has agreed to remain with the Company thereafter for a period of up to twelve months in order to effect an orderly handover.

 

Steve Scott, a non-executive director of Quindell, has agreed with the Company that he will step down from the Board with immediate effect.

 

The Board remains confident in the future prospects of the business.

 

David Currie, Quindell's non-Executive Interim Chairman, commented:

 

"Rob is the founder of the business and has made a huge contribution to Quindell's growth to date and the Board thanks him for that. We look forward to completing our search for a new Chairman and additional non-executive directors as soon as possible."

 

Robert Terry said:

 

"I entered into the share transactions announced on 5 November 2014, with the best of intentions for the Company and all shareholders and it would have been my intention to acquire more shares were it not for the restrictions due to the discussions leading to this announcement. I am clearly disappointed and sorry that events turned out as they did.

 

"In view of the share price performance of the last few days, it is likely that a margin call will be made in relation to the share transactions and, at the current share price, I would expect to relinquish my rights to acquire 8,850,000 shares under the EFH Sale and Repurchase Agreement, rather than satisfying the margin call as this would now no longer make economic sense. This will draw a line under this Agreement and I have no intention of making further use of this Agreement or its like again."

 

For further information:

 

Quindell Plc Tel: 01489 864200

David Currie, non-Executive Interim Chairman

Stephen Joseph, Head of Investor Relations

 

Cenkos Securities plc, Nominated Adviser and broker Tel: 020 7397 8900

Stephen Keys/Mark Connolly

 

Bell Pottinger Tel: 020 3772 2562

Victoria Geoghegan/Will Powell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABPBFTMBJBMFI
Date   Source Headline
5th Dec 201110:54 amPRNForm 8.3 - Quindell Portfolio Plc
5th Dec 20119:58 amRNSForm 8.3 - Quindell Portfolio Plc
5th Dec 20117:00 amRNSRule 2.10 Announcement
2nd Dec 20111:39 pmRNSEarly settlement of TMS Earnout
2nd Dec 20117:00 amRNSRecommended Share Offer for Mobile Doctors
1st Dec 201110:58 amRNSForm 8.3 - Quindell Portfolio Plc
30th Nov 20112:00 pmRNSTotal Voting Rights
29th Nov 201110:36 amRNSForm 8.3 - Quindell Portfolio Plc
28th Nov 20119:07 amRNSForm 8.3 - Quindell Portfolio Plc
25th Nov 20113:54 pmRNSTMC (Southern) Ltd - Form 8.3 - Quindell
25th Nov 201110:40 amRNSForm 8.3 - Quindell Portfolio Plc
18th Nov 20117:00 amRNSAppointment of Joint Broker
17th Nov 20115:32 pmRNSForm 8 (OPD) Mobile Doctors Group Plc
17th Nov 20114:38 pmRNSJohn Stretton-Knowles - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMatthew Whiting - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSNeil McGrigor - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMark Read - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSSimon Rand - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTony Smith - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSJames Eneas - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSDominic Milton - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTMC (Southern) Limited - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSBradley Wingrave - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSForm 8 (OPD) (Quindell Portfolio Plc)
17th Nov 20114:37 pmRNSForm 8 (OPD) (Mobile Doctors)
17th Nov 20114:37 pmRNSRule 2.10 Announcement
10th Nov 20117:00 amRNSPartnership with SMI Telecoms LLC
7th Nov 20112:57 pmRNSForm 8.3 - Quindell Portfolio Plc
4th Nov 20119:54 amRNSPossible Offer for Mobile Doctors
1st Nov 20117:00 amRNSAcquisition of Maine Finance Limited
31st Oct 20117:00 amRNSTotal Voting Rights
26th Oct 20117:00 amRNSIntegration of Acquired Businesses
21st Oct 201110:58 amRNSDirector Shareholdings/Significant Shareholders
19th Oct 201110:56 amRNSDirector/PDMR Shareholding
19th Oct 20119:56 amRNSDirector/PDMR Shareholding
19th Oct 20117:00 amRNSFurther Investment in Mobile Doctors Group plc
17th Oct 201110:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSSeven new Contract wins and Trading Update
10th Oct 20117:10 amRNSFurther Investment in Mobile Doctors Group plc
10th Oct 20117:00 amRNSAppointment of Financial PR Advisor
1st Aug 20117:00 amRNSTotal Voting Rights
25th Jul 20117:01 amRNSInvestment in MDG.L and Board Appointment
25th Jul 20117:01 amRNSDirector/PDMR Shareholding
25th Jul 20117:00 amRNSHalf Yearly Report
22nd Jul 20117:00 amRNSAcquisition
21st Jul 20117:00 amRNSInvestment in digital insurance brand Ingenie
18th Jul 20117:00 amRNSChange of Name
14th Jul 201111:24 amRNSIssue of Warrants
14th Jul 201111:23 amRNSResults of General Meeting
11th Jul 20114:02 pmRNSChanges to significant shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.